India's Opto Circuits expands with Criticare
This article was originally published in Clinica
Executive Summary
Bangalore-based Opto Circuits, said to be one of India's leading healthcare equipment manufacturers, is to grow its patient monitoring business with the acquisition of US firm Criticare Systems. Opto definitively agreed on Monday (Feb 25) to buy Milwaukee, Wisconsin-based Criticare for $5.50 per share, giving the total transaction a value of $68m. The purchase price represents a 19% premium over Criticare's closing price on Feb 22.
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.